New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials

BACKGROUND: New direct-acting antiviral agents (DAAs) approved for the treatment of patients infected by Hepatitis C virus (HCV) are well tolerated and increase sustained virological response (SVR) rate. We summarize current evidence on the efficacy and safety from comparative randomized controlled...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Exp Hepatol
Egile Nagusiak: Pecoraro, Valentina, Banzi, Rita, Cariani, Elisabetta, Chester, Johanna, Villa, Erica, D'Amico, Roberto, Bertele', Vittorio, Trenti, Tommaso
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2019
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6728536/
https://ncbi.nlm.nih.gov/pubmed/31516269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2018.07.004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak